No takes yet. Share an insight, caveat, or question.
Experiments reveal variable radiosensitivity and outcomes in prostate cancer models treated with radioligand therapy, indicating complexities in clinical efficacy.
Everard et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: